Pill to treat COVID-19 cuts risk of hospitalization or death in half
A pill to treat COVID-19 that cut hospitalizations and deaths in half could become the first oral medication against the disease.
Antiviral reduces COVID-19 hospitalizations by 87%
The FDA-approved antiviral drug remdesivir prevents high-risk people from ending up in the hospital, if given early.
A malaria antibody prevented infections in purposefully-infected volunteers
In a small study, researchers found an antibody that prevents malaria infection in people purposefully infected with the parasite.
Johns Hopkins has developed a lung cancer blood test
Researchers at Johns Hopkins are using AI to power a lung cancer blood test.
Want better nasal vaccines? Look to the bacteria in your nose.
Researchers are investigating the link between the bacteria inside your nose and how effective nasal vaccines can be.
This implanted microchip may one day control your sleep
An implantable, wireless device could be better than popping a pill.
UK researchers are growing the Delta variant for human challenge trials
Responding to the variant’s rise, UK researchers are growing the Delta variant for trials.